【创新药概念再度走强 舒泰神涨超15%创3年新高】早盘舒泰神涨超15%,股价创3年多新高,键凯科技、博瑞医药、健友股份、三生国健、益方生物等涨幅靠前。消息面上,舒泰神公告,STSA-1002注射液在急性呼吸窘迫综合征(ARDS)适应症下获得了Ib/II期临床试验研究的初步结果。28天全因死亡率数据显示,低剂量组和高剂量组分别为26.67%和5.88%,较对照组的40%分别降低了33.33%和85.3%。

金融界
May 29, 2025
早盘舒泰神涨超15%,股价创3年多新高,键凯科技博瑞医药健友股份三生国健益方生物等涨幅靠前。消息面上,舒泰神公告,STSA-1002注射液在急性呼吸窘迫综合征(ARDS)适应症下获得了Ib/II期临床试验研究的初步结果。28天全因死亡率数据显示,低剂量组和高剂量组分别为26.67%和5.88%,较对照组的40%分别降低了33.33%和85.3%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10